RE:RE:RE:Approval for Phase 2b/3 Hi Talisman
i appreciate your optimism, however realistically if data comes back in 3-4 months that's still fast. Being said
the streetwise article is contrary to their very optimistic news releases.
June 25 news release excerpt:
Study Start Date
Enrollment of the 1st patient for the Phase 2b/3 study is expected before the end of July 2020. It is difficult to assess at this time what the enrollment rate for the study will be across all countries and all sites selected.
However, based on the rising number of reported COVID infections in certain countries, the Company is presently not concerned about achieving the enrollment of the 150 patients for its study in a reasonable time period. After the study begins, the Company will make an assessment of the enrollment rate and will provide an update to the market on a projected competition date as well as when the data will be expected.
Not bashing here just can't make heads or tails. If it's a typo from streetwise fine but somebody should be editing that $hit. If not somebody is talking out both sides of their mouth.
Truthfully I don't care because I've held shares since Breathtec and I'm long but
misleading forward looking statements aren't cool. I wish they'd stop pandering to these media marketing companies and just give the straight goods.
Maybe I've been drinking AlgernonsKoolaid lol but just seems like there's a rat in the woodshed.
We'll see soon
Hopefully you're right and I'm wrong!
cheers Talisman
GLTA